- June 23, 2025Introduction Navigating regulatory approvals demands precision, expertise, and collaboration. Our long-standing partnership with a global biopharmaceutical leader has driven success…
- May 22, 2025Background A clinical-stage company developing innovative cell therapies for cancer and immune-mediated diseases partnered with Syner-G BioPharma Group to scale…
- February 17, 2025A leading biopharmaceutical company focused on developing innovative solutions in drug development and delivery faced a significant challenge: they needed…
- January 17, 2025
- January 17, 2025
- December 10, 2024Background Syner-G Biotech Consulting recently partnered with a global leader in nucleic acid and mRNA production to implement an optimized…
November 11, 2024How Syner-G BioPharma Facilitated Regulatory Submissions for a Major U.S. Biopharmaceutical Company to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)- October 30, 2024
June 3, 2024About The client is a clinical-stage biotechnology company focused on the phase III development of an anti-interleukin-6 monoclonal antibody therapeutic…- June 3, 2024About The client is a U.S.-based clinical-stage biotechnology company using artificial intelligence (AI) and human data to transform drug discovery…
